What is pathophysiology of Alzheimer?

['ⵙⵎⴷ ⵜⴰⵖⴹⴼⵜ ⴰⴷ']

ⵎⴰⴷ ⵉⴳⴰⵏ ⵜⴰⴼⵉⵣⵉⴽⵓⵍⵓⵊⵉⵜ ⵜⴰⴱⴰⵜⵓⵊⵉⵜ ⵏ ⴰⵍⵣⵀⴰⵢⵎⵔ?

ⵜⴳⴰ ⵜⵎⴰⵙⵙⴰⵏⵜ ⵏ ⵜⴷⵓⵙⵉ ⵜⴰⴱⴰⵜⵓⵊⵉⵜ ⵏ ⵜⵎⴰⴹⵓⵏⵜ ⵏ ⴰⵍⵣⵀⴰⵢⵎⵔ ⵢⴰⵜ ⵜⵎⴳⴳⵉⵜ ⵜⴰⵔⵡⵙⴰⵏⵜ ⵏⵏⴰ ⵢⵓⵎⵥⵏ ⴰⵙⵎⵓⵏ ⵏ ⵉⴱⵔⵓⵜⵉⵏⵏ ⵓⵔ ⵜⵍⵍⵉ ⵜⵎⵢⵓⵔⵜ, ⴷ ⵓⵙⵙⵓⵏⴼⵓ, ⴷ ⵜⴰⵡⵓⵔⵉ ⵓⵔ ⵜⵍⵍⵉ ⵏ ⵉⵏⵉⵔⵏ.

ⵙⵉⵏ ⵉⴼⵔⴷⵉⵙⵏ ⵉⵙⵜⴰⵡⵀⵎⵎⴰⵏ ⵏ ⵡⴰⵟⵟⴰⵏ ⵏ ⴰⵍⴷⵓⵏⵉⵙⵢⴰ ⴳⴰⵏ ⵉⵍⵍⴰ ⴱⵍⴰⴽⵉⵎ ⵏ ⴰⵎⵉⵍⵓⵉⴷ-ⴱⵉⵜⴰ (ⴰ) ⴷ ⵜⴱⵍⴽⵉⵎⵉⵏ ⵏ ⵉⵏⵢⵔⵓⴼⵉⴱⵔⵉⵍⵍⴰⵔⵉ (ⵏⴼⵜ) ⴳ ⵓⵏⵍⵍⵉ.

ⴷⴰ ⵜⵜⵓⵙⴽⴰⵔⵏⵜ ⵜⵇⴰⵕⵉⴹⵉⵏ ⵏ ⴱⵉⵜⴰ ⴰⵎⵉⵍⵓⵉⴷ ⵍⵍⵉⵖ ⴷⴰ ⵜⵜⵓⵙⴼⵍⴰⵙⵏⵜ ⵉⴼⵔⴷⵉⵙⵏ ⵏ ⵓⴱⵕⵓⵜⵉⵏ ⴰⵎⵉⵍⵓⵉⴷ ⴰⵎⵣⵡⴰⵔⵓ (APP) ⵙ ⵉⴽⵏⵉⵡⵏ ⴰⴼⴰⴷ ⴰⴷ ⵜⵜⵓⵙⴽⴰⵔⵏⵜ ⵜⴱⵓⴱⵜⵉⴷⴰⴷⵉⵏ ⵏ Aβ.

ⴷⴰ ⵜⵜⵎⵓⵏⵏⵜ ⵜⴱⵢⴱⵜⵉⴷⵉⵏ ⴰⴷ ⴰⵔ ⵜⵜⵓⵙⴽⴰⵔⵏⵜ ⵉⴼⵉⵍⴰⵏ ⵓⵔ ⵉⵜⵜⵔⵎⴰⵢⵏ ⵏⵏⴰ ⵉⵜⵜⵎⵓⵏⵏ ⴱⵕⵕⴰ ⵏ ⵉⵏⵢⵓⵔⵓⵏⵏ, ⴰⵔ ⵜⵜⵔⵥⵥⵓⵏ ⴰⵎⵢⴰⵡⴰⴹ ⵏ ⵜⵖⵔⴰⵙⵜ ⵙ ⵜⵖⵔⴰⵙⵜ ⴰⵔ ⵉⵜⵜⴰⵡⵉⵏ ⵙ ⵜⵎⵜⵜⴰⵏⵜ ⵏ ⵉⵏⵢⵓⵔⵓⵏⵏ.

ⴷⴰ ⵜⵜⵉⵖⵉⵍ ⵉⵙ ⵉⴳⴰ ⵓⵙⵎⵓⵏ ⵏ ⵉⵙⵏⴰⴳⴰⵔⵏ ⵏ "ⴰⴱⴰⴱ" ⵢⴰⵏ ⵙⴳ ⵉⵎⵣⵣⵓⵜⵏ ⵉⵎⵣⵡⵓⵔⴰ ⴳ ⵓⴱⵓⵖⵍⵓ ⵏ ⵡⴰⵟⵟⴰⵏ ⵏ ⵍⵄⴰⵍⴰⵎⵉ, ⴷ ⴷⴰ ⵜⵜⵉⵖⵉⵍ ⵉⵙ ⴷ ⵉⵔⵡⵙ ⴳ ⵜⵎⴳⴳⵉⵜ ⵜⴰⴱⵓⵖⵍⵓⵢⵜ ⵏ ⵓⵏⴳⵔⴰⵡ ⴰⵏⵣⴳⵓⵏ.

ⴷⴰ ⵜⵜⵓⵙⴽⴰⵔⵏⵜ ⵜⵔⴰⴱⴱⵓⵜⵉⵏ ⵏ ⵉⴼⵉⵍⴰⵏ ⵉⵏⵖⵓⴱⵓⵢⵏ ⵍⵍⵉⵖ ⴷⴰ ⵉⵜⵜⵉⵍⵉ ⵓⵀⵉⴱⵉⵔⴼⵓⵙⴼⵓⵔⵉⵍ ⵏ ⵓⴼⵔⵓⵜⵉⵏ ⵜⴰⵜⴰⵡⵜ ⴰⵔ ⵉⵜⵜⵓⵙⴽⴰⵔ ⵉⴼⵉⵍⴰⵏ ⵓⵔ ⵢⴰⴽⵙⵓⵍⵏ ⴳ ⵓⴳⵏⵙⵓ ⵏ ⵉⵏⵖⵓⴱⵓⵢⵏ.

ⴷⴰ ⵜⵜⵓⵙⵙⴱⴷⴷⴰⴷⵏ ⵉⵖⵔⵔⴰⴱⵓⵜⵏ ⴰⴷ ⵅⴼ ⵜⵡⵓⵔⵉ ⵜⴰⵣⴷⴷⴰⴳⵜ ⵏ ⵜⵣⵇⵇⴰ ⵜⵉⵎⵥⵥⵢⴰⵏⵉⵏ, ⵏⵏⴰ ⵉⴳⴰⵏ ⵜⵉⵔⵙⵍⵜ ⵜⴰⴷⵙⵍⴰⵏⵜ ⵉ ⵓⵙⵎⵓⵜⵜⴳ ⵏ ⵉⵎⵙⵎⴰⵜⵜⴰⵢⵏ ⴷ ⵜⵎⵜⵜⵉⵡⵉⵏ ⵢⴰⴹⵏⵉⵏ ⴳ ⵡⴰⵏⵙⴰ ⵏ ⵜⵖⵔⴰⵙⵜ.

ⴷⴰ ⵜⵜⴰⵡⵉⵏⵜ ⵜⵇⵔⴱⴰⵢⵍⵉⵏ ⵙ ⵜⵉⴳⵉⵔⴰ ⵖⵔ ⵜⵎⵜⵜⴰⵏⵜ ⵏ ⵉⵏⵢⵓⵔⵓⵏⵏ ⵉⴹⵙⵔⵏ.

ⴷⴰ ⵜⵓⵔⴰⵔ ⴰⵡⴷ ⵜⴳⵓⴹⵉ ⵢⴰⵏ ⵜⵉⵍⴰⵍⵜ ⴳ ⵜⵙⵏⴼⵍⵓⵍⵓⵊⵉⵜ ⵜⴰⴱⴰⵜⵓⵃⵉⵊⵉⵜ ⵏ ⵡⴰⵟⵟⴰⵏ ⵏ ⴰⵍⴷⵣⴰⵢⵔ.

ⴷⴰ ⵉⵜⵜⵔⴰⵔ ⵓⵏⴳⵔⴰⵡ ⵏ ⵜⵓⴽⴽⵙⵉ ⵉ ⵓⵙⵎⵓⵏ ⵏ ⵉⵙⵔⵔⴰⵙⵏ ⵏ Aβ ⴷ NFT ⵙ ⵓⵙⵓⴼⵖ ⵏ ⵜⵙⵉⵟⵓⴽⵉⵏⵉⵏ ⵜⵉⴱⵔⴰⵔⴳⵉⵏ, ⵏⵏⴰ ⵉⵖⵉⵏ ⴰⴷ ⵙⵙⵔⵇⴱⵏ ⴰⵙⵏⴳⵓ ⵉ ⵉⵏⵢⵓⵔⵓⵏⵏ.

ⵙ ⵓⵙⵎⵔⵙ ⵏ ⵎⴰⵢⴰ, ⵍⵍⴰⵏⵜ ⵜⵎⵉⵜⴰⵔ ⵏ ⵓⵙⵙⵓⵔⵙ ⵏ ⵓⴽⵙⵉⴷ, ⴷ ⵜⴰⵡⵓⵔⵉ ⵓⵔ ⵉⵃⵍⵉⵏ ⵏ ⵍⵎⵉⵜⵓⴽⵓⵏⴷⵔⵉⵢ, ⴷ ⵓⵙⵏⴼⵍ ⵏ ⵓⴽⵕⵉⴹ ⴳ ⵍⴳⵍⵓⵣⵓⵣ ⵉⴽⵛⵎⵏ ⴳ ⵜⵙⵏⴼⵍⵓⵍⵓⵊⵉⵜ ⵜⴰⴱⴰⵜⵓⵊⵉⵜ ⵏ ⵡⴰⵟⵟⴰⵏ ⵏ ⴰⵍⴷⵣⴰⵢⵔ.

ⵣⵎⵔⵏ ⵉⴼⵔⴷⵉⵙⵏ ⴰⴷ ⴰⴷ ⴰⵡⵉⵏ ⵖⵔ ⵜⵊⵊⵉⵜ ⵏ ⵜⵉⴳⴰⵡⵜ ⵏ ⵉⵏⵉⵔⵓⵏ ⴷ ⵜⵎⵜⵜⴰⵏⵜ, ⴰⵢⵏⵏⴰ ⵉⵙⵖⵓⴷⵓ ⵜⴰⵖⴰⵔⴰ ⵏ ⵜⵎⴰⴹⵓⵏⵜ.

ⵙ ⵓⵎⴰⵜⴰ, ⵜⴰⴱⴰⵜⵓⴼⵉⵣⵉⵢⵓⵍⵓⵊⵉⵜ ⵏ ⵡⴰⵟⵟⴰⵏ ⵏ ⵍⵄⴰⵍⴰⵎⵉ ⵜⴳⴰ ⵢⴰⵜ ⵜⵎⵔⴽⵉⵜ ⵜⵓⴷⴷⵉⵙⵜ ⵏ ⴽⵉⴳⴰⵏ ⵏ ⵉⵎⵙⴽⴰⵔⵏ ⵏⵏⴰ ⴷ ⵢⵓⵡⵉⵏ ⴳ ⵜⴳⵉⵔⴰ ⵖⵔ ⵜⵣⵔⵉⴳⵜ ⵜⴰⵎⵖⵓⵔⴰⵏⵜ ⴳ ⵜⵡⵓⵔⵉ ⵏ ⵓⵙⵎⵓⵙⵙⵓ ⴷ ⵜⵍⴽⴰⵎⵉⵏ ⵏ ⵜⵍⴽⴰⵎⵉⵏ ⵏ ⵜⵍⴽⴰⵎⵉⵏ ⵏ ⵜⵍⴽⴰⵎⵉⵏ ⵏ ⵜⵍⴽⴰⵎⵉⵏ ⵏ ⵜⵍⴽⴰⵎⵉⵏ ⵏ ⵜⵍⴽⴰⵎⵉⵏ ⵏ ⵜⵍⴽⴰⵎⵉⵏ ⵏ ⵜⵍⴽⴰⵎⵉⵏ ⵏ ⵜⵍⴽⴰⵎⵉⵏ ⵏ ⵜⵍⴽⴰⵎⵉⵏ.

['ⵉⵙⵓⴳⴰⵎ']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Nemeroff CB: The preeminent role of neuropeptide systems in the early pathophysiology of Alzheimer disease: up with corticotropin-releasing factor, down with acetylcholine. Arch Gen Psychiatry. 1999, 56 (11): 991-2.

Skoog I, Kalaria RN, Breteler MM: Vascular factors and Alzheimer disease. Alzheimer Dis Assoc Disord. , 13 Suppl 3 (): S106-14.

Proft J, Weiss N: Jekyll and Hide: The two faces of amyloid β. Commun Integr Biol. 2012, 5 (5): 405-7.

Whitehouse PJ, Hedreen JC, White CL, Price DL: Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol. 1983, 13 (3): 243-8.

Casadesus G, Moreira PI, Nunomura A, Siedlak SL, Bligh-Glover W, Balraj E, Petot G, Smith MA, Perry G: Indices of metabolic dysfunction and oxidative stress. Neurochem Res. , 32 (4-5): 717-22.

Candore G, Bulati M, Caruso C, Castiglia L, Colonna-Romano G, Di Bona D, Duro G, Lio D, Matranga D, Pellicanò M, Rizzo C, Scapagnini G, Vasto S: Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications. Rejuvenation Res. , 13 (2-3): 301-13.

Raskind MA, Peskind ER: Neurobiologic bases of noncognitive behavioral problems in Alzheimer disease. Alzheimer Dis Assoc Disord. 1994, 8 Suppl 3 (): 54-60.

Schindler SE, McConathy J, Ances BM, Diamond MI: Advances in diagnostic testing for Alzheimer disease. Mo Med. , 110 (5): 401-5.

Singh VK: Immune-activation model in Alzheimer disease. Mol Chem Neuropathol. , 28 (1-3): 105-11.

['ⴰⵙⴱⴷⵉⴷ: ⴰⵎⵙⵏⵉⵊⵊⵉ']

['ⴰⵙⵉⵜ ⴰⴷ, ⴷⴰ ⵉⵜⵜⵓⴼⴽⴰ ⵖⴰⵙ ⵉ ⵜⵖⴰⵡⵙⵉⵡⵉⵏ ⵏ ⵓⵙⴳⵎⵉ ⴷ ⵉⵏⵖⵎⵉⵙⵏ, ⵓⵔ ⵉⴳⵉ ⴰⵖⴰⵡⴰⵙ ⵏ ⵜⵉⴽⴽⵉ ⵏ ⵜⵉⵏⵓⵔⵣⵉⵜⵉⵏ ⵜⵉⴷⵓⵙⴰⵏⵉⵏ ⵏⵖⴷ ⵜⵉⵡⵓⵔⵉⵡⵉⵏ ⵜⵉⵣⵣⵓⵍⴰⵏⵉⵏ.']

['ⵓⵔ ⵉⵅⵚⵚⴰ ⴰⴷ ⵜⵜⵓⵙⵎⵔⵙ ⵉⵏⵖⵎⵉⵙⵏ ⵉⵜⵜⵓⴼⴽⴰⵏ ⴳ ⵓⵙⵎⵔⵙ ⵏ ⵓⵙⵎⵉⴳⵍ ⵏⵉⵖ ⵉⵊⵉⵊⵊⵉ ⵏ ⵉⵎⵓⴽⵔⵉⵙⵏ ⵏ ⵜⴷⵓⵙⵉ ⵏⵖⴷ ⵜⵎⴰⴹⵓⵏⵉⵏ, ⴷ ⵡⵉⵏⵏⴰ ⵉⵔⴰⵏ ⴰⵙⵖⵏⵓ ⴰⵎⵙⵏⵉⵊⵊⵉ ⴰⵡⵏ ⵉⵜⵜⵓⴼⴽⴰⵏ ⵉⵇⵇⴰⵏ ⴰⴷ ⵉⵙⴰⵡⵍ ⴷ ⵢⴰⵏ ⵓⵎⵙⵏⵉⵊⵊⵉ ⵉⵜⵜⵓⵊⵊⴰⵏ.']

['ⵙⵙⴽⵜⵉ ⴳ ⵜⴱⵔⴰⵜ ⵎⴰⵙ ⵜⵣⵟⵟⴰ ⵏ ⵜⵎⴰⵖⵓⵏⵜ ⵏⵏⴰ ⵉⵜⵜⴰⵔⴰⵏ ⵜⵉⵎⵔⴰⵔⵓⵜⵉⵏ ⵉ ⵉⵙⵇⵙⵉⵜⵏ, ⵓⵔ ⵜⴽⴽⵉ ⵜⵖⴰⵔⴰ ⴽⵉⴳⴰⵏ ⴳ ⵎⴰⴷ ⵉⵥⵍⵉⵏ ⵙ ⵜⵓⵎⴰⵢⵜ ⵏ ⵓⵟⵟⵓⵏ. ⵙ ⵓⵎⴷⵢⴰ, ⵓⵟⵟⵓⵏ ⵏ ⵎⴷⴷⵏ ⵉⵜⵜⵓⵙⵏⴼⴰⵍⵏ ⵉ ⵜⵎⴰⴹⵓⵏⵜ ⵉⵥⵍⵉⵏ.']

['ⴰⵀⴰ ⵣⵣⵔⵉⵢ ⵉ ⵓⵎⵙⴰⵙⴰ ⵏ ⵓⴷⵓⴽⵜⵓⵕ ⵏⵏⴽ ⵏⵖⴷ ⴽⵔⴰ ⵏ ⵓⵎⵙⵙⵉⵡⵍ ⵏ ⵜⴷⵓⵙⵉ ⵢⴰⴹⵏ ⵉⵖⵉⵢⵏ ⴳ ⵎⴰⴷ ⵉⵥⵍⵉⵏ ⵙ ⵓⴷⴷⴰⴷ ⵏ ⵜⴷⵓⵙⵉ ⵏⵏⴽ. ⵓⵔ ⴰⴽⴽⵡ ⵜⵃⵍⴰⵎ ⴰⵖ ⴰⵖⴰⵎⵓⵙ ⵏ ⵓⴷⵓⵙⵉ ⵏⵖⴷ ⵜⵉⵖⵣⵉ ⴳ ⵓⵙⵣⵣⵔⵉⵢ ⵏⵏⵙ ⴰⵛⴽⵓ ⵏⵜⵜⴰⵜ ⵜⵖⵔⵉⴷ ⴳ ⵓⵙⵉⵜ ⴰⴷ. ⵎⴽ ⵜⵓⵔⴷⴰ ⵎⴰⵙ ⴷⴰⵔⴽ ⴰⴷ ⵢⵉⵍⵉ ⵢⴰⵏ ⵓⴷⴷⴰⴷ ⵏ ⵜⴷⵓⵙⵉ ⵉⵣⵉⵍⵏ, ⵙⴰⵡⵍⴰⵜ ⵙ 911 ⵏⵖⴷ ⴷⴷⵓ ⵙ ⵓⵙⵉⵔⴰ ⵏ ⵓⵣⵣⵔⴰⵢ ⵏ ⵣⵉⴽⴽ. ⵓⵔ ⴷⴰ ⵉⵜⵜⵓⵙⴽⴰⵔ ⴽⵔⴰ ⵏ ⵓⵣⴷⴰⵢ ⵏ ⵓⵎⵙⴳⵏⴰⴼ ⴷ ⵓⵎⵏⵉⴳ ⵙ ⵓⵙⵉⵜ ⴰⴷ ⵏⵖⴷ ⴰⵙⵎⵔⵙ ⵏⵏⵙ. ⵓⵔ ⴷⴰ ⵜⵙⴽⴰⵔ ⴱⵢⵓⵎⵉⴷⵍⴱ ⵏⵖⴷ ⵉⵎⵙⵡⵓⵔⵉⵏ ⵏⵏⵙ ⵏⵖⴷ ⴽⵔⴰ ⵏ ⵓⵎⴷⵔⴰⵡ ⴳ ⵓⵙⵉⵜ ⴰⴷ ⴽⵔⴰ ⵏ ⵓⵙⵎⵏⵉⴷ, ⵙ ⵡⴰⵡⴰⵍ ⵏⵖⴷ ⵙ ⵓⵙⵓⵎⵔ, ⴳ ⵎⴰⴷ ⵉⵥⵍⵉⵏ ⵙ ⵉⵏⵖⵎⵉⵙⵏ ⵉⵜⵜⵓⴼⴽⴰⵏ ⴳ ⵓⵙⵉⵜ ⴰⴷ ⵏⵖⴷ ⵓⵙⵎⵔⵙ ⵏⵏⵙ.']

['ⵉⵣⵍⵉ: ⵉⵣⵔⴼⴰⵏ ⵏ ⵜⵉⵔⵔⴰ']

['ⵉⵍⵍⴰ ⴳ ⵓⵙⵍⴳⵏ ⵏ ⵓⵣⵔⴼ ⴰⵎⵓⵟⵟⵓⵏ ⵏ ⵓⵙⵏⴼⵍ ⵏ ⵜⵏⵖⵎⴰⵙⵜ ⵏ ⵓⵙⴳⴳⵡⴰⵙ ⵏ 1998, 17 U.S.C. § 512 (DMCA) ⵜⴰⵙⵏⵜⴰⵢⵜ ⵉ ⵉⵎⵥⵢⴰⵏⵏ ⵏ ⵉⵣⵔⴼⴰⵏ ⵏ ⵜⵏⵖⵎⴰⵙⵜ ⵏⵏⴰ ⵙⵙⵉⵜⵉⵎⵏ ⵉⵙ ⵉⵏⵖⵎⵉⵙⵏ ⵏⵏⴰ ⴷ ⵉⵜⵜⴼⴼⵖⵏ ⴳ ⵡⴰⵏⵜⵉⵔⵏⵉⵜ ⴷⴰ ⵜⵜⴳⴳⴰⵏ ⵉⵣⵔⴼⴰⵏ ⵏⵏⵙⵏ ⴷⴷⴰⵡ ⵓⵣⵔⴼ ⴰⵎⵓⵟⵟⵓⵏ ⴰⵎⵉⵔⵉⴽⴰⵏⵉ. ']

['ⵎⴽ ⵜⵍⵍⵉⴷ ⵙ ⵜⵖⴰⵍⵜ ⵉⵖⵓⴷⴰⵏ ⵎⴰⵙⴷ ⴽⵔⴰ ⵏ ⵜⵓⵎⴰⵢⵜ ⵏⵖⴷ ⴽⵔⴰ ⵏ ⵓⵙⵏⴼⴰⵔ ⵉⵜⵜⵓⴼⴽⴰⵏ ⴳ ⵓⵙⴷⴰⵡ ⵏⵏⵓⵏ ⵏⵖⴷ ⵜⵉⵙⵏⵙⵉ ⵏⵏⵓⵏ ⴷⴰ ⵉⵙⵙⴽⴰⵔ ⵜⵉⵕⵥⵉ ⵏ ⵓⵣⵔⴼ ⵏⵏⵓⵏ ⵏ ⵜⵉⵔⵔⴰ, ⵉⵖⵢ ⴰⴷ ⵜⴰⴷ ⴼⵍⵍⴰⵙ ⵏⵙⵔⵖⴷ (ⵏⵖⴷ ⴰⵎⴷⵢⴰⵣ ⵏⵏⴽ) ⵢⴰⵏ ⵓⵙⵏⵖⵎⵙ ⵏ ⵓⵙⵓⵜⵔ ⵏ ⵓⵙⵏⴼⴰⵔ ⵏ ⵜⵓⵎⴰⵢⵜ ⵏⵖⴷ ⴰⵙⵏⴼⴰⵔ ⴰⴷ ⵏⵖⴷ ⴰⵙⴱⴷⴷⵉ ⵏ ⵓⵣⵔⴼ ⵏ ⵓⴽⵛⵛⵓⵎ ⵖⵔⵙⵏ. ']

['ⵉⵇⵇⴰⵏ ⴰⴷ ⵜⵜⵢⵓⵔⴰⵢ ⵜⴱⵔⴰⵜ ⴰⴷ ⵙ ⵜⵖⴰⵔⴰⵙⵜ ⵏ ⵜⵉⵔⵔⴰ ⵙ ⵜⴱⵔⴰⵜ ⵜⵉⵍⵉⴽⵜⵕⵓⵏⵉⵜ (ⵥⵕ ⴰⵙⴷⴰⵡ ⵏ ⵜⴱⵔⴰⵜ ⵜⵉⵍⵉⴽⵜⵕⵓⵏⵉⵜ ⴳ ⵓⵎⵏⵏⵉ "ⵉⵎⵢⴰⵡⴰⴹⵏ").']

['ⴷⴰ ⵉⵜⵜⴻⵖⵜⴰⵙ ⵓⵙⵍⴳⵏ ⵏ ⵓⵎⵏⵖⵉ ⵅⴼ ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⵎⴳⴰⵢ ⵉⵙ ⴷ ⵉⵇⵇⴰⵏ ⴰⴷ ⴳⵉⵙ ⵉⵍⵉⵏ ⵉⵏⵖⵎⵉⵙⵏ ⴰⴷ: (1) ⴰⵙⵏⵓⵎⵍ ⵏ ⵜⵡⵓⵔⵉ ⵉⵍⴰⵏ ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⵎⴳⴰⵢ ⵏⵏⴰ ⵉⴳⴰⵏ ⴰⵙⵏⵜⵍ ⵏ ⵓⵣⵔⴼ ⵏ ⵓⵎⴳⴰⵢ; (2) ⴰⵙⵏⵓⵎⵍ ⵏ ⵜⵓⵎⴰⵢⵜ ⵏⵏⴰ ⵉⴳⴰⵏ ⴰⵙⵏⵓⵎⵍ ⵏ ⵉⵣⵔⴼⴰⵏ ⴷ ⵉⵏⵖⵎⵉⵙⵏ ⵏⵏⴰ ⵢⵓⵙⴰⵏ ⵃⵎⴰ ⴰⴷ ⵜ ⵏⴰⴼ; (3) ⵉⵏⵖⵎⵉⵙⵏ ⵏ ⵓⵎⵢⴰⵡⴰⴹ ⴰⴽⴷⴽ, ⴳ ⵉⵍⵍⴰ ⵓⵙⵖⵉⵎ ⵏⵏⴽ ⴷ ⵓⵟⵟⵓⵏ ⵏ ⵜⵉⵍⵉⴼⵓⵏ ⴷ ⵓⴷⵖⴰⵔ ⵏ ⵍⵢⵉⴱⵍ; (4) ⴰⵙⵉⵡⴹ ⵏⵏⴽ ⵏ ⵓⵙⵏⵓⵎⵍ ⵉⵖⵓⴷⴰⵏ ⵏⵏⴰ ⴳ ⵜⵍⵍⴰ ⵜⵣⵎⵎⴰⵔ ⵏ ⵓⵙⵏⵓⵎⵍ ⵏ ⵓⵙⵏⴼⵍ ⵏⵏⴰ ⵙ ⵉⵜⵜⵓⵙⵎⴳⴰⵍ ⵓⵔ ⵜ ⵢⵓⵊⵊⵉ ⵓⵎⵏⴳⴰⵢ ⵏ ⵉⵣⵔⴼⴰⵏ ⵏ ⵓⵎⴳⴰⵢ, ⵏⵖⴷ ⵓⵎⴷⵢⴰⵣ ⵏⵏⵙ, ⵏⵖⴷ ⵙ ⵓⴹⴼⴰⵕ ⵏ ⴽⵔⴰ ⵏ ⵓⵙⵍⴳⵏ; ']

['5. ⵢⴰⵏ ⵓⵙⵉⵡⴹ ⵏⵏⴽ, ⵉⵜⵜⵓⵙⴳⵎⴰⴹⵏ ⴷⴷⵓ ⵏ ⵓⵃⵟⵟⵓ ⵏ ⵜⵔⴳⴰⵍⵜ, ⵎⴰⵙ ⵉⵏⵖⵎⵉⵙⵏ ⵉⵍⵍⴰⵏ ⴳ ⵓⵏⵖⵎⵉⵙ ⴰⴷ ⴳⴰⵏ ⵉⵙⴷⴰⵡⵏ ⴷ ⵎⴰⵙ ⵖⵓⵔⴽ ⵜⵓⵔⴰⴳⵜ ⴰⴼⴰⴷ ⴰⴷ ⵜⵙⵎⴷⵔⴼ ⵜⵉⵡⵏⴳⵉⵎⵉⵏ ⵉⵜⵜⵉⵏⵉ ⵉⵙ ⵜⵜⵓⵙⵏⴼⴰⵍⵏ;']

['ⴷ (6) ⵢⴰⵏ ⵓⵣⵎⵎⴻⵎ ⴰⴽⵎⴰⵎ ⵏⵖⴷ ⴰⵍⵉⴽⵜⵔⵓⵏⵉ ⵏ ⵉⵎⵥⵍⵉ ⵏ ⵓⵣⵔⴼ ⵏ ⵜⵉⵔⵔⴰ ⵏⵖⴷ ⵢⴰⵏ ⵓⴼⴳⴰⵏ ⵉⵜⵜⵓⵙⵎⴰⴳⵍⵏ ⵙ ⵜⵡⵓⵔⵉ ⴳ ⵜⵙⴳⴰ ⵏ ⵉⵎⵥⵍⵉ ⵏ ⵓⵣⵔⴼ ⵏ ⵜⵉⵔⵔⴰ. ']

['ⵎⴽ ⵓⵔ ⵜⵙⵎⵓⵜⵜⵉⴷ ⴽⵓⵍⵍⵓ ⵉⵏⵖⵎⵉⵙⵏ ⴰⴼⵍⵍⴰ, ⵉⵥⴹⴰⵕ ⴰⴷ ⵉⵙⵙⵉⵍⵉ ⵓⵙⵙⵉⵖⵣⵉⵏ ⵏ ⵓⵙⵎⴽⵍ ⵏ ⵡⴰⵙⵉⴼ ⵏⵏⴽ.']

['ⴰⵎⵢⴰⵡⴰⴹ']

['ⵙⵇⵙⴰⵖ ⴷⵉⵖ ⴰⴷ ⵜⵙⵏⵖⵎⵙⴷ ⴽⵔⴰ ⵏ ⵓⵙⵇⵙⵉ/ ⵜⴰⵏⵏⴰⵢⵜ.']

What is pathophysiology of alzheimer?

The pathophysiology of Alzheimer's disease (AD) is a complex process that involves the accumulation of abnormal proteins, inflammation, and neuronal dysfunction.

The two main hallmarks of AD are the presence of amyloid-beta (Aβ) plaques and neurofibrillary tangles (NFTs) in the brain.

Amyloid-beta plaques are formed when fragments of the amyloid precursor protein (APP) are cleaved by enzymes to form Aβ peptides.

These peptides aggregate and form insoluble fibrils that accumulate outside neurons, disrupting cell-to-cell communication and leading to neuronal death.

The accumulation of Aβ plaques is thought to be one of the earliest events in the development of AD, and it is believed to contribute to the neurodegenerative process.

Neurofibrillary tangles are formed when the protein tau becomes hyperphosphorylated and forms abnormal filaments inside neurons.

These tangles disrupt the normal functioning of the microtubules, which are essential for the transport of nutrients and other materials within the neuron.

The tangles eventually lead to the death of the affected neurons.

Inflammation also plays a role in the pathophysiology of AD.

The immune system responds to the accumulation of Aβ plaques and NFTs by releasing pro-inflammatory cytokines, which can exacerbate the damage to neurons.

Additionally, there is evidence that oxidative stress, mitochondrial dysfunction, and impaired glucose metabolism contribute to the pathophysiology of AD.

These factors can lead to neuronal dysfunction and death, further exacerbating the disease process.

Overall, the pathophysiology of AD is a complex interplay of multiple factors that ultimately lead to the progressive decline in cognitive function and memory loss that characterizes the disease.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.

['ⵖⴼ']

['ⴷⴰ ⵉⵙⵙⵎⵔⴰⵙ ⴱⵢⵓⵎⵉⴷⵍⴱ ⵉⵎⴰⵙⵙⵏ ⵏ ⵓⵙⵖⵉⵡⵙ ⵉⵙⵎⵎⴰⵏⵏ (ⴰⵍⴳⵓⵔⵉⵜⵎ ⵏ ⵓⵍⵎⵎⵓⴷ ⵏ ⵉⵎⵉⵙⵏ) ⵉ ⵓⵙⵓⴼⵖ ⵏ ⵉⴽⵔⵡⴰⵏ ⵏ ⵉⵙⵇⵙⵉⵜⵏ ⴷ ⵜⵎⵔⴰⵔⵓⵜⵉⵏ.']

['ⴷⴰ ⵏⵙⵙⵏⵜⵉ ⵙ 35 ⵎⵍⵢⵓⵏ ⵏ ⵜⵥⵕⵉⴳⵉⵏ ⵜⵉⵎⵙⵏⵉⵊⵊⵉⵏ ⵏ ⵜⵓⴷⵔⵜ ⵏ ⴱⵓⴱⵎⵉⴷ/ⵎⵉⴷⵍⵉⵏ. ⴰⵡⴷ ⵜⵉⴼⵔⵜ ⵏ ⵡⵉⴱ ⵏ ⵔⵉⴼⵉⵏⴷⵡⵉⴱ.']

['ⵥⵕ "ⵜⵓⵎⴰⵔ" ⴰⵡⴷ "ⴰⵙⵎⵉⴳⵍ".']